MHC binding peptide [5142]
MHC binding peptide
| SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O |
| InChIKey |
LZOIGVDSAMDBIO-LXWJMTKESA-N |
| Sequence |
MYFINILTL |
| HELM |
PEPTIDE1{M.Y.F.I.N.I.L.T.L}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
14 |
| Hydrogen bond donors |
13 |
| Rotatable bonds |
35 |
| Log P |
0.661 |
| Molecular weight (Da) |
1126.6 |
| Stereochemistry info |
partial |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.